Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Avelumab|DRUG: Endocrine therapy|DRUG: Palbociclib
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: Pfizer|Allegheny Health Network|National Institutes of Health (NIH)